Ind-Swift Limited — Important, 24-12-2024: Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

Ind Swift Limited's 100% Export Oriented Unit (Global Business Unit) has received the GMP Compliance Certificate from ROF Germany, following a successful inspection conducted from 27th November to 4th December, 2024. This certification, validating the manufacturing of Metformin tablets in various dosages, is effective until 3rd June, 2026.

This achievement strengthens the company's operational capabilities and positions it favorably in the export market, enhancing shareholder value. Investor sentiment may lean positively as this certification underscores compliance with international standards, reducing potential risks associated with product quality and market access.